Is there a generic for Vilazodone hydrochloride?

Yes. The FDA Orange Book lists 5 approved generic (ANDA) applications for Vilazodone hydrochloride, referencing the brand VIIBRYD. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

What is the reference-listed drug for Vilazodone hydrochloride?

VIIBRYD (NDA 022567, ABBVIE) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Vilazodone hydrochloride are approved?

Vilazodone hydrochloride is approved in the following dosage form: tablet.

FDA Orange Book · active-ingredient family

Vilazodone hydrochloride

Vilazodone hydrochloride is approved as 1 brand and 5 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:VIIBRYD · NDA 022567

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · tablet

Product	Applicant	Application	TE	Approved
VIIBRYDRLD×3	ABBVIE	NDA 022567	AB	Jan 21, 2011

Generic (ANDA) products (5)

Product	Applicant	Application	TE	Approved
VILAZODONE HYDROCHLORIDE×3	APOTEX	ANDA 208228	AB	Jul 07, 2023
VILAZODONE HYDROCHLORIDE×3	ACCORD HLTHCARE	ANDA 208209	AB	Apr 27, 2021
VILAZODONE HYDROCHLORIDE×3	INVAGEN PHARMS	ANDA 208200	AB	Apr 07, 2021
VILAZODONE HYDROCHLORIDE×3	ALEMBIC	ANDA 208202	AB	Jan 10, 2020
VILAZODONE HYDROCHLORIDE×3	TEVA PHARMS USA	ANDA 208212	AB	Sep 30, 2019

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Vilazodone hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo